秦偉偉，校聘教授，博士生導(dǎo)師

安徽醫(yī)科大學(xué)藥學(xué)科學(xué)學(xué)院基礎(chǔ)與臨床藥理學(xué)教研室PI；2020年獲中國藥科大學(xué)中藥學(xué)院中藥學(xué)專業(yè)(藥理學(xué)方向)理學(xué)博士學(xué)位；畢業(yè)之后繼續(xù)在中國科學(xué)技術(shù)大學(xué)生命科學(xué)與醫(yī)學(xué)部從事博士后科學(xué)研究。主要研究方向?yàn)閮?nèi)分泌與代謝性肝病研究及相關(guān)藥物研發(fā)。主持國家自然科學(xué)基金面上、青年項(xiàng)目和安徽省自然科學(xué)基金面上、青年項(xiàng)目等。代表作發(fā)表在Science Bulletin、Journal of Lipid Research、Journal of Ethnopharmacology等學(xué)術(shù)期刊。

研究方向：代謝性疾病藥理學(xué)

電子郵箱：qinww@ahmu.edu.cn

辦公室：知行樓B1411

主持課題項(xiàng)目情況：

1.國家自然科學(xué)基金面上項(xiàng)目，2026/01-2029/12，在研；

2.安徽省自然科學(xué)基金面上項(xiàng)目，2025/09-2028/08，在研；

3.安徽醫(yī)科大學(xué)人才啟動(dòng)項(xiàng)目，2024/07-2029/07，在研；

4.國家自然科學(xué)基金青年項(xiàng)目，2022/01-2024/12，結(jié)題；

5.安徽省自然科學(xué)基金青年項(xiàng)目，2021/01-2023/12，結(jié)題；

6.中國博士后科學(xué)基金面上項(xiàng)目，2021/06-2023/06，結(jié)題。

代表作：

1.Weiwei Qin#, Yu Ding#, Wenhao Zhang, Lu Sun, Jianping Weng, Xueying Zheng*, Sihui Luo*. Small molecule-driven LKB1 deacetylation is responsible for the inhibition of hepatic lipid response in NAFLD.J Lipid Res. 2025, 100740.

2.Weiwei Qin, Jianping Weng*. Hepatocyte NLRP3 interacts with PKCε to drive hepatic insulin resistance and steatosis.Sci. Bull. 2023, 68: 1413-1429.

3.Weiwei Qin#, Xiyang Tong#, Rongyao Liang, Kai Tang, Xingdong Wu, Yuning Jia*, Ninghua Tan*. Preservation of mitochondrial homeostasis is responsible for the ameliorative effects of Suhuang antitussive capsule on nonresolving inflammation via inhibition of NF-κB signaling and NLRP3 inflammasome activation.J. Ethnopharmacol. 2021, 271: 113827.

4.Weiwei Qin#, Xingdong Wu#, Yuning Jia#, Xiyang Tong, Chao Guo, Dong Chen*, Zhen Wang*, Ninghua Tan*. Suhuang antitussive capsule inhibits NLRP3 inflammasome activation and ameliorates pulmonary dysfunctionvia suppression of endoplasmic reticulum stress in cough variant asthma.Biomed. Pharmacother. 2019, 118: 109188.

5.Weiwei Qin, Junxiao Xi, Baiqiu He, Baobao Zhang, Huiling Luan, Feihua Wu*. Ameliorative effects of hispidulin on high glucose-mediated endothelial dysfunctionvia inhibition of PKCβII-associated NLRP3 inflammasome activation and NF-κB signaling in endothelial cells.J. Funct. Foods, 2016, 27: 392-405.

6.Weiwei Qin#, Bei Ren#, Shanshan Wang, Shujun Liang, Baiqiu He, Xiaoji Shi, Liying Wang, Jingyu Liang, Feihua Wu*. Apigenin and naringenin ameliorate PKCβII-associated endothelial dysfunctionvia regulating ROS/caspase-3 and NO pathway in endothelial cells.Vasc.Pharmacol, 2016, 85: 39-49.

7.Ying Wang, Xueru Wang, Kaijin Wang,Weiwei Qin*, Ning Li*. Extract ofcurculigo capitulata ameliorates postmenopausal osteoporosis by promoting osteoblast proliferation and differentiation.Cells. 2024, 13: 2028.